Skip to Main Content

Paper Details

AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin.
Pharmacogenomics J
14
2016
Author NameAffiliation
Ole Christian Lingj??rdeUniversity of Oslo
Ole Christian Lingj??rdeK.G. Jebsen Center for Breast Cancer Research, Institute for Cancer Research, Oslo University Hospital
  • 1 - 2

Datasets

Release 1.2